In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrre B, Wilson DP (eds) Endotext
These peptides arent FDA-approved for human use, but under medical supervision they may represent a cutting-edge tool in regenerative medicine
10.3390/nu11092073 [DOI] [PMC free article] [PubMed] [Google Scholar] 329.Hermel M, Sweeney M, Ni Y-M, Bonakdar R, Triffon D, Suhar C, et al
Regnier M, Flammier S, Boutaba M, Ndongo AA, Servais A, Schaefer F, Levtchenko E, Bacchetta J, Bertholet-Thomas A (2024) Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective
This has resulted in hypo-cystinemia, with plasma cystine concentrations decreasing to 30% below baseline, as described in 12 patients with cirrhosis who received a FreeAmmine II source of amino acids in their intravenous hyperalimentation
This matters because, as the National Institute of Arthritis and Musculoskeletal and Skin Diseases explains, autoimmune disease occurs when the immune system mistakenly attacks healthy tissue